Rather ironic that many praised the company for their ambitions not for the shareholders, but for the development of a life-changing drug for hundreds of thousands, if not eventually millions of people. Now it's getting slapped because the cap raise wasn't available for retail participation?
Surely such a milestone is celebrated, rather individuals are finding the pessimism in progression?
They've secured essential funding which can be leveraged for exponential development in the year to come.
Have some conviction in your investments...
cheers
Ann: Argenica Successfully Completes $12.0m Placement, page-15
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
83.0¢ |
Change
-0.045(5.14%) |
Mkt cap ! $105.1M | |||
| Open | High | Low | Value | Volume |
| 84.8¢ | 85.0¢ | 82.5¢ | $72.50K | 87.17K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 40212 | 82.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 83.0¢ | 21465 | 1 |
View Market Depth
| Last trade - 11.22am 17/07/2024 (20 minute delay) ? |
| AGN (ASX) Chart |